Google Alert - GE

	GE Daily update ⋅ March 1, 2023
	NEWS
	GE HealthCare, Sinopharm plan imaging-focused joint venture - Fierce Biotech Fierce Biotech More than 30 years after GE HealthCare first joined forces with Sinopharm, China's state-run drugmaker, the partners are renewing their vows. Flag as irrelevant
	Why Did I Sell Most Of My General Electric Shares? (NYSE:GE) | Seeking Alpha Seeking Alpha General Electric's revenue was $21787 million in the Q4 22, showing a positive vs. previous quarter and the last three months of 2021. Flag as irrelevant
	GE HealthCare Stock: A Compelling Opportunity (NASDAQ:GEHC) | Seeking Alpha Seeking Alpha GE HealthCare rallied over 30% since going public. Medical imaging market is large and continues to expand as early diagnosis is critical for ... Flag as irrelevant
	GE HealthCare inks new joint venture aimed at broadening access to imaging Radiology Business GE's new partnership will initially focus on providing CT and ultrasound imaging solutions to rural geographies and primary care providers, according ... Flag as irrelevant
	General Electric (GE) Files $20B Mixed Shelf - StreetInsider StreetInsider General Electric (NYSE: GE) has filed $20,000,000,000 mixed shelf of: Debt Securities. Preferred Stock. Common Stock. Flag as irrelevant
	GE Renewable Energy Installs First Commercial Spiral-Welded Wind Turbine Tower Renewable Energy Magazine The installation is the result of a multi-year collaboration between Keystone and GE to design and produce spiral-welded towers for GE wind turbines. Flag as irrelevant
	GE releases 2022 Annual Report - ZAWYA ZAWYA GE ended the year with solid revenue growth and margin expansion, and $4.8 billion of free cash flow. GE Aerospace led the way with order and revenue ... Flag as irrelevant
	GE HealthCare pursues partnership with Chinese state-owned medtech firm Becker's Hospital Review GE HealthCare is entering a joint venture with state-owned China National Medical Device Co., part of Chinese medical giant Sinopharm, ... Flag as irrelevant
	General Electric (NYSE:GE) Given Average Recommendation of "Moderate Buy" by Analysts MarketBeat General Electric (NYSE:GE - Get Rating) has earned a consensus rating of "Moderate Buy" from the sixteen analysts that are presently covering the ... Flag as irrelevant
	SonoThera™ Receives Exclusive Licensing of GE HealthCare's Optison® and ... - Business Wire Business Wire SonoThera™ Receives Exclusive Licensing of GE HealthCare's Optison® and Sonazoid® Microbubble Products in its Ultrasound-guided Gene Therapy ... Flag as irrelevant
See more results | Edit this alert

You have received this email because you have subscribed to Google Alerts. Unsubscribe | View all your alerts

Receive this alert as RSS feed

Send Feedback